🚀 VC round data is live in beta, check it out!
DarioHealth Valuation Multiples
Discover revenue and EBITDA valuation multiples for DarioHealth and similar public comparables like Acer Medical, Deepnoid, Vanfund Urban Investment, Data Horizon and more.
DarioHealth Overview
About DarioHealth
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Founded
2011
HQ
Employees
202
Website
Financials (LTM)
EV
$58M
DarioHealth Financials
DarioHealth reported last 12-month revenue of $24M and negative EBITDA of ($22M).
In the same LTM period, DarioHealth generated $14M in gross profit, ($22M) in EBITDA losses, and had net loss of ($38M).
Revenue (LTM)
DarioHealth P&L
In the most recent fiscal year, DarioHealth reported revenue of $22M and EBITDA of ($24M).
DarioHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $24M | XXX | $22M | XXX | XXX | XXX |
| Gross Profit | $14M | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | 61% | XXX | 57% | XXX | XXX | XXX |
| EBITDA | ($22M) | XXX | ($24M) | XXX | XXX | XXX |
| EBITDA Margin | (92%) | XXX | (107%) | XXX | XXX | XXX |
| EBIT Margin | (94%) | XXX | (108%) | XXX | XXX | XXX |
| Net Profit | ($38M) | XXX | ($42M) | XXX | XXX | XXX |
| Net Margin | (163%) | XXX | (187%) | XXX | XXX | XXX |
| Net Debt | — | — | $9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
DarioHealth Stock Performance
DarioHealth has current market cap of $52M, and enterprise value of $58M.
Market Cap Evolution
DarioHealth's stock price is $7.17.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $58M | $52M | -4.5% | XXX | XXX | XXX | $-5.71 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialDarioHealth Valuation Multiples
DarioHealth trades at 2.5x EV/Revenue multiple, and (2.7x) EV/EBITDA.
EV / Revenue (LTM)
DarioHealth Financial Valuation Multiples
As of April 17, 2026, DarioHealth has market cap of $52M and EV of $58M.
Equity research analysts estimate DarioHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
DarioHealth has a P/E ratio of (1.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $52M | XXX | $52M | XXX | XXX | XXX |
| EV (current) | $58M | XXX | $58M | XXX | XXX | XXX |
| EV/Revenue | 2.5x | XXX | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | (2.7x) | XXX | (2.4x) | XXX | XXX | XXX |
| EV/EBIT | (2.6x) | XXX | (2.4x) | XXX | XXX | XXX |
| EV/Gross Profit | 4.1x | XXX | 4.6x | XXX | XXX | XXX |
| P/E | (1.4x) | XXX | (1.3x) | XXX | XXX | XXX |
| EV/FCF | (2.0x) | XXX | (2.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified DarioHealth Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
DarioHealth Margins & Growth Rates
DarioHealth's revenue in the last 12 month grew by 28%.
DarioHealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.
DarioHealth's rule of 40 is (42%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
DarioHealth's rule of X is (15%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
DarioHealth Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 28% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | (92%) | XXX | (107%) | XXX | XXX | XXX |
| EBITDA Growth | (45%) | XXX | (34%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (42%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (15%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 80% | XXX | 91% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 56% | XXX | 68% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 54% | XXX | 62% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 221% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
DarioHealth Public Comps
See public comps and valuation multiples for other Digital Therapeutics and Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| DarioHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Acer Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Deepnoid | XXX | XXX | XXX | XXX | XXX | XXX |
| Vanfund Urban Investment | XXX | XXX | XXX | XXX | XXX | XXX |
| Data Horizon | XXX | XXX | XXX | XXX | XXX | XXX |
| Oncocross | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
DarioHealth M&A Activity
DarioHealth acquired XXX companies to date.
Last acquisition by DarioHealth was on XXXXXXXX, XXXXX. DarioHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by DarioHealth
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialDarioHealth Investment Activity
DarioHealth invested in XXX companies to date.
DarioHealth made its latest investment on XXXXXXXX, XXXXX. DarioHealth invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by DarioHealth
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout DarioHealth
| When was DarioHealth founded? | DarioHealth was founded in 2011. |
| Where is DarioHealth headquartered? | DarioHealth is headquartered in United States. |
| How many employees does DarioHealth have? | As of today, DarioHealth has over 202 employees. |
| Who is the CEO of DarioHealth? | DarioHealth's CEO is Erez Raphael. |
| Is DarioHealth publicly listed? | Yes, DarioHealth is a public company listed on Nasdaq. |
| What is the stock symbol of DarioHealth? | DarioHealth trades under DRIO ticker. |
| When did DarioHealth go public? | DarioHealth went public in 2013. |
| Who are competitors of DarioHealth? | DarioHealth main competitors are Acer Medical, Deepnoid, Vanfund Urban Investment, Data Horizon. |
| What is the current market cap of DarioHealth? | DarioHealth's current market cap is $52M. |
| What is the current revenue of DarioHealth? | DarioHealth's last 12 months revenue is $24M. |
| What is the current revenue growth of DarioHealth? | DarioHealth revenue growth (NTM/LTM) is 28%. |
| What is the current EV/Revenue multiple of DarioHealth? | Current revenue multiple of DarioHealth is 2.5x. |
| Is DarioHealth profitable? | No, DarioHealth is not profitable. |
| What is the current EBITDA of DarioHealth? | DarioHealth has negative EBITDA and is not profitable. |
| What is DarioHealth's EBITDA margin? | DarioHealth's last 12 months EBITDA margin is (92%). |
| What is the current EV/EBITDA multiple of DarioHealth? | Current EBITDA multiple of DarioHealth is (2.7x). |
| What is the current FCF of DarioHealth? | DarioHealth's last 12 months FCF is ($30M). |
| What is DarioHealth's FCF margin? | DarioHealth's last 12 months FCF margin is (126%). |
| What is the current EV/FCF multiple of DarioHealth? | Current FCF multiple of DarioHealth is (2.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.